Author: OurCrowd

[Alpha Tau in GlobeNewswire] Alpha Tau to present at Biotech Showcase and participate in LifeSci Advisors Corporate Access Event during J.P. Morgan Healthcare Conference in San Francisco in January 2023

JERUSALEM, Dec. 13, 2022 (GLOBE NEWSWIRE) — Alpha Tau Medical Ltd. (Nasdaq: DRTS, DRTSW) (“Alpha Tau,” or the “Company”), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today that the Company plans to present at the Biotech Showcase™ and host institutional investor meetings at this event, as well as at the LifeSci Partners Corporate Access Event. Both in-person events are taking place in parallel with the 41st Annual J.P. Morgan Healthcare Conference which will be held January 9-12, 2023 in San Francisco, California. Read...

Read More